Various studies have correlated
apolipoprotein (
apo) A-I, the major component
high-density lipoprotein, with protection against development of
cardiovascular disease. Although
apoA-I expression has been previously detected in the liver and intestine, we have discovered that the human
apoA-I gene is also expressed in the heart. Using transgenic (Tg) mice generated with the human
apoA-I/C-III/A-IV gene cluster and Tg mice produced with just the 2.2 kb human
apoA-I gene, we have detected significant levels of
apoA-I expression in the heart. Furthermore, the detection of
apoA-I expression in the hearts of human
apoA-I Tg mice indicates that the minimal regulatory elements necessary for cardiac expression of the gene are located near its coding sequence. To determine if the
apoA-I gene is also expressed in the human heart, similar analyses were performed, where
apoA-I expression was found in both adult and fetal hearts. Furthermore in-depth investigation of the various regions of human and Tg mouse hearts revealed that the
apoA-I mRNA was present in the ventricles and atria, but not in the aorta. In situ hybridization of Tg mouse hearts revealed that
apoA-I expression was restricted to the cardiac myocyte cells. Finally, heart explants and cardiac primary culture experiments with Tg mice showed secretion of particles containing the human
apoA-I protein, and metabolic labeling experiments have also detected a 28 kDa human
apoA-I protein secreted from the heart. From these novel findings, new insights into the role and function of
apoA-I can be extrapolated.